| Product Code: ETC7306448 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Germany Giant Cell Arteritis Market Overview |
3.1 Germany Country Macro Economic Indicators |
3.2 Germany Giant Cell Arteritis Market Revenues & Volume, 2021 & 2031F |
3.3 Germany Giant Cell Arteritis Market - Industry Life Cycle |
3.4 Germany Giant Cell Arteritis Market - Porter's Five Forces |
3.5 Germany Giant Cell Arteritis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Germany Giant Cell Arteritis Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 Germany Giant Cell Arteritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of giant cell arteritis in Germany |
4.2.2 Rising geriatric population in Germany |
4.2.3 Advancements in diagnostic technologies for giant cell arteritis |
4.2.4 Growing awareness among healthcare professionals about giant cell arteritis |
4.2.5 Favorable government initiatives for healthcare infrastructure development in Germany |
4.3 Market Restraints |
4.3.1 High cost of treatment for giant cell arteritis |
4.3.2 Limited availability of specialized healthcare facilities for giant cell arteritis patients |
4.3.3 Adverse effects associated with current treatment options for giant cell arteritis |
4.3.4 Stringent regulatory requirements for approval of new treatments in Germany |
4.3.5 Lack of standardized guidelines for the management of giant cell arteritis in Germany |
5 Germany Giant Cell Arteritis Market Trends |
6 Germany Giant Cell Arteritis Market, By Types |
6.1 Germany Giant Cell Arteritis Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Germany Giant Cell Arteritis Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Germany Giant Cell Arteritis Market Revenues & Volume, By Corticosteroid Therapy, 2021- 2031F |
6.1.4 Germany Giant Cell Arteritis Market Revenues & Volume, By Others (Monoclonal Antibody), 2021- 2031F |
6.2 Germany Giant Cell Arteritis Market, By End-Use |
6.2.1 Overview and Analysis |
6.2.2 Germany Giant Cell Arteritis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Germany Giant Cell Arteritis Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Germany Giant Cell Arteritis Market Revenues & Volume, By Ascs, 2021- 2031F |
6.2.5 Germany Giant Cell Arteritis Market Revenues & Volume, By Others, 2021- 2031F |
7 Germany Giant Cell Arteritis Market Import-Export Trade Statistics |
7.1 Germany Giant Cell Arteritis Market Export to Major Countries |
7.2 Germany Giant Cell Arteritis Market Imports from Major Countries |
8 Germany Giant Cell Arteritis Market Key Performance Indicators |
8.1 Average time to diagnosis of giant cell arteritis in Germany |
8.2 Number of clinical trials focused on giant cell arteritis in Germany |
8.3 Patient adherence rate to prescribed treatment regimens |
8.4 Healthcare provider knowledge level about giant cell arteritis management |
8.5 Patient satisfaction with access to giant cell arteritis healthcare services |
9 Germany Giant Cell Arteritis Market - Opportunity Assessment |
9.1 Germany Giant Cell Arteritis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Germany Giant Cell Arteritis Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 Germany Giant Cell Arteritis Market - Competitive Landscape |
10.1 Germany Giant Cell Arteritis Market Revenue Share, By Companies, 2024 |
10.2 Germany Giant Cell Arteritis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |